Startseite>>Signaling Pathways>> Tyrosine Kinase>> c-MET>>Ficlatuzumab

Ficlatuzumab

Katalog-Nr.GC69110

Ficlatuzumab is a monoclonal antibody (McAb) that targets human hepatocyte growth factor (HGF). Ficlatuzumab can block the activation of the HGF/c-Met signaling pathway, inhibiting c-Met receptor-mediated cancer cell proliferation, migration and invasion.

Products are for research use only. Not for human use. We do not sell to patients.

Ficlatuzumab Chemische Struktur

Cas No.: 1174900-84-5

Größe Preis Lagerbestand Menge
5mg
787,50 $
Auf Lager
10mg
1.260,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Bewertungen

Review for Ficlatuzumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ficlatuzumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.